title: An IL-1 receptor and an IL-1 receptor antagonist attenuate muramyl dipeptide- and IL-1-induced sleep and fever.
abstract: It is hypothesized that the somnogenic and pyrogenic effects of muramyl dipeptide (MDP) are mediated via enhanced interleukin-1 (IL-1) production. To test this hypothesis the effects of intracerebroventricular (icv) administration of a recombinant human soluble type I IL-1 receptor (sIL-1r) and of the IL-1 receptor antagonist (IL-1ra) on MDP-induced sleep and fever were evaluated in rabbits. The sIL-1r recognized rabbit IL-1 beta, but it did not affect sleep or brain temperature across the dose range tested (1-50 micrograms) when injected icv into normal rabbits. Pretreatment of rabbits with 50 micrograms sIL-1r or 10 micrograms IL-1ra blocked human recombinant IL-1-enhanced nonrapid eye movement (NREM) sleep and fever. Thus both the sIL-1r and the IL-1ra were effective antagonists of IL-1 actions. When the animals were pretreated with either 50 micrograms sIL-1r or with 10 or 100 micrograms of the IL-1ra, the somnogenic effects of 150 pmol MDP were attenuated. However, the sIL-1r had little effect on MDP-induced febrile responses. These results suggest that the sIL-1r and the IL-1ra can function as antagonists of IL-1 actions in vivo and that MDP-induced sleep and fever are partially mediated by IL-1.
authors.affiliation: Department of Physiology and Biophysics, University of Tennessee, Memphis 38163.
authors.forename: L
authors.initials: L
authors.lastname: Imeri
authors.forename: M R
authors.initials: MR
authors.lastname: Opp
authors.forename: J M
authors.initials: JM
authors.lastname: Krueger
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D005334:Fever / Q000139:chemically induced / Q000517:prevention & control*; D007276:Injections, Intraventricular; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D011817:Rabbits; D011930:Reaction Time; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors* / Q000502:physiology*; D012890:Sleep / Q000187:drug effects*; D012894:Sleep Stages / Q000187:drug effects
chemical_list: D007375:Interleukin-1; D017472:Receptors, Interleukin-1; D000119:Acetylmuramyl-Alanyl-Isoglutamine